A 27-year-old woman with Kallmann syndrome (congenital GnRH deficiency) desires pregnancy. She has been on estrogen-progesterone replacement for bone health. Her physician plans to switch her to pulsatile GnRH therapy. After 6 weeks of treatment, labs show: LH 4 mIU/mL, FSH 5 mIU/mL, estradiol 120 pg/mL. Ultrasound shows a 16mm dominant follicle. Evaluate and synthesize the physiologic response to determine the appropriate next intervention for ovulation induction.
Q2
A 30-year-old woman at 28 weeks gestation with gestational diabetes managed with insulin presents with decreased fetal movement. Fetal monitoring shows category II tracing. Umbilical artery Doppler shows absent end-diastolic flow. Her glucose control has been suboptimal (HbA1c 7.8%). Maternal blood pressure is normal. Synthesize the pathophysiologic relationship between her metabolic condition and the Doppler findings to determine the primary mechanism.
Q3
A 42-year-old woman with previously regular 28-day cycles now reports cycles varying from 24-35 days over the past year. Day 3 labs show: FSH 18 mIU/mL (normal: 3-10), LH 10 mIU/mL, estradiol 35 pg/mL, AMH 0.4 ng/mL (normal age 40-44: 0.5-2.5). She has three children and desires no future pregnancies but wants to understand her physiology. Evaluate these findings and synthesize the underlying pathophysiologic process.
Q4
A 38-year-old G3P2 woman at 39 weeks gestation presents in active labor. She has a history of postpartum hemorrhage with her second delivery requiring transfusion. After delivery of the infant, the placenta is delivered intact 8 minutes later. Her obstetrician administers oxytocin. Ten minutes postpartum, she has moderate vaginal bleeding. Analyze the physiologic mechanisms and determine the most likely cause of bleeding.
Q5
A 26-year-old woman with regular menses undergoes hormonal evaluation on day 3 of her cycle: FSH 8 mIU/mL, LH 6 mIU/mL, estradiol 45 pg/mL. On day 14, repeat testing shows: FSH 10 mIU/mL, LH 42 mIU/mL, estradiol 250 pg/mL. On day 21: progesterone 16 ng/mL, estradiol 150 pg/mL. Analyze this hormonal pattern to identify the physiologic mechanism driving the day 14 LH surge.
Q6
A 29-year-old woman at 10 weeks gestation develops severe hyperemesis gravidarum. Ultrasound reveals a complete hydatidiform mole. Her serum hCG is 500,000 mIU/mL. She undergoes suction curettage. Two weeks post-procedure, her hCG is 50,000 mIU/mL. Four weeks post-procedure, it is 45,000 mIU/mL. Analyze these findings to determine the most appropriate next step.
Q7
A 35-year-old woman undergoes in vitro fertilization with embryo transfer on day 3 post-retrieval. Her ovarian stimulation protocol included recombinant FSH and GnRH antagonist, with hCG trigger 36 hours before retrieval. On the day of transfer (day 3), what would be the expected dominant hormone maintaining the endometrium, and what is its primary source?
Q8
A 24-year-old nulliparous woman presents with secondary amenorrhea for 6 months. She is a competitive marathon runner training 70 miles per week with 12% body fat. Labs show: LH 1.2 mIU/mL (normal follicular phase: 2-10), FSH 2.1 mIU/mL (normal: 3-10), estradiol 15 pg/mL (normal follicular: 30-100), prolactin 14 ng/mL (normal: <25), TSH 2.1 mIU/L. Apply these findings to determine the mechanism of her amenorrhea.
Q9
A 32-year-old woman at 8 weeks gestation presents with nausea and vomiting. Laboratory studies show: hCG 150,000 mIU/mL (expected for gestational age: 50,000-100,000 mIU/mL), TSH 0.1 mIU/L (normal: 0.4-4.0), free T4 1.8 ng/dL (normal: 0.8-1.8). She has no personal or family history of thyroid disease. Apply your understanding of pregnancy hormones to explain these findings.
Q10
A 28-year-old woman presents to the clinic for evaluation of infertility. Her menstrual cycles have been regular every 28 days. She reports using basal body temperature charting, which shows a biphasic pattern with temperature elevation occurring around day 14. Serum progesterone is measured on day 21 of her cycle and is found to be 18 ng/mL (normal luteal phase >10 ng/mL). Based on this information, what is the most likely status of her ovulatory function?
Reproductive physiology (menstrual cycle, pregnancy) US Medical PG Practice Questions and MCQs
Question 1: A 27-year-old woman with Kallmann syndrome (congenital GnRH deficiency) desires pregnancy. She has been on estrogen-progesterone replacement for bone health. Her physician plans to switch her to pulsatile GnRH therapy. After 6 weeks of treatment, labs show: LH 4 mIU/mL, FSH 5 mIU/mL, estradiol 120 pg/mL. Ultrasound shows a 16mm dominant follicle. Evaluate and synthesize the physiologic response to determine the appropriate next intervention for ovulation induction.
A. Continue current GnRH dosing and monitor for spontaneous LH surge
B. Add clomiphene citrate to augment endogenous gonadotropin release
C. Increase GnRH pulse frequency to stimulate endogenous LH surge
D. Administer exogenous hCG to trigger ovulation and time intercourse (Correct Answer)
E. Switch to gonadotropin therapy with recombinant FSH and LH
Explanation: ***Administer exogenous hCG to trigger ovulation and time intercourse***
- In **Kallmann syndrome**, the absence of **GnRH neurons** means the patient cannot generate a spontaneous **LH surge** despite follicular maturation; **exogenous hCG** acts as an **LH analog** to trigger ovulation.
- The labs and ultrasound demonstrate successful **follicular development** with a **16mm follicle** and adequate **estradiol**, indicating the patient is ready for the final maturation trigger.
*Continue current GnRH dosing and monitor for spontaneous LH surge*
- A spontaneous surge will not occur because the patient lacks the endogenous **hypothalamic GnRH** release mechanism required to respond to **estrogen positive feedback**.
- Relying on the pump's fixed frequency will not mimic the necessary mid-cycle **GnRH surge** needed for natural ovulation.
*Add clomiphene citrate to augment endogenous gonadotropin release*
- **Clomiphene citrate** works by blocking **estrogen receptors** in the hypothalamus to increase GnRH; it is ineffective in Kallmann syndrome due to the lack of **functional GnRH neurons**.
- Therapeutic success in these patients requires bypassing the hypothalamus using either **pulsatile GnRH** or direct **gonadotropin therapy**.
*Increase GnRH pulse frequency to stimulate endogenous LH surge*
- Increasing pulse frequency does not replicate the complex **positive feedback** kinetics required to generate a massive **LH surge** in GnRH-deficient individuals.
- Fixed-frequency pulsatile pumps are designed for **folliculogenesis** but are generally insufficient to achieve the threshold required for **oocyte release** without additional triggers.
*Switch to gonadotropin therapy with recombinant FSH and LH*
- This switch is unnecessary because the patient is already showing an excellent physiologic response to **pulsatile GnRH therapy**, as evidenced by her **FSH**, **LH**, and **dominant follicle**.
- Pulsatile GnRH is often preferred when available because it maintains the **pituitary-ovarian axis** and carries a lower risk of **ovarian hyperstimulation syndrome (OHSS)** compared to exogenous gonadotropins.
Question 2: A 30-year-old woman at 28 weeks gestation with gestational diabetes managed with insulin presents with decreased fetal movement. Fetal monitoring shows category II tracing. Umbilical artery Doppler shows absent end-diastolic flow. Her glucose control has been suboptimal (HbA1c 7.8%). Maternal blood pressure is normal. Synthesize the pathophysiologic relationship between her metabolic condition and the Doppler findings to determine the primary mechanism.
A. Maternal hyperglycemia causing fetal hyperinsulinemia and increased oxygen consumption
B. Maternal ketoacidosis causing direct fetal myocardial depression
C. Fetal polycythemia from chronic hypoxia increasing blood viscosity
D. Uteroplacental insufficiency from diabetes-induced vasculopathy affecting spiral arteries (Correct Answer)
E. Placental hypertrophy from fetal macrosomia compressing umbilical cord
Explanation: ***Uteroplacental insufficiency from diabetes-induced vasculopathy affecting spiral arteries***
- **Absent end-diastolic flow (AEDF)** in the umbilical artery signifies high **placental vascular resistance**, often due to maternal **decidual vasculopathy** and endothelial damage.
- Suboptimal glucose control in diabetes leads to **microvascular changes** in the **spiral arteries**, reducing oxygen and nutrient delivery, which results in placental insufficiency and compromised fetal wellbeing.
*Maternal hyperglycemia causing fetal hyperinsulinemia and increased oxygen consumption*
- While **maternal hyperglycemia** leads to **fetal hyperinsulinemia**, this metabolic state primarily drives **fetal macrosomia** and elective oxygen demand rather than structural vascular resistance in the umbilical artery.
- Increased oxygen consumption contributes to **fetal hypoxemia**, but it does not mechanistically explain the **AEDF** seen on Doppler studies.
*Fetal polycythemia from chronic hypoxia increasing blood viscosity*
- **Fetal polycythemia** is a compensatory response to **chronic hypoxia** triggered by erythropoietin release; it is a consequence rather than the primary driver of umbilical artery flow obstruction.
- Although increased **blood viscosity** can affect flow, the primary lesion in **AEDF** is high resistance within the **placental villous bed** due to vascular pathology.
*Maternal ketoacidosis causing direct fetal myocardial depression*
- **Maternal ketoacidosis** is an acute, life-threatening emergency that can cause **fetal distress**, but there is no clinical evidence (such as pH or anion gap) provided to support this diagnosis here.
- **AEDF** is typically a marker of chronic **placental resistance** over time, whereas myocardial depression would more likely reflect as **fetal bradycardia** or loss of variability.
*Placental hypertrophy from fetal macrosomia compressing umbilical cord*
- **Placental hypertrophy** is commonly associated with **gestational diabetes**, but the placenta does not compress the umbilical cord to the point of causing **AEDF**.
- **Umbilical cord compression** usually presents as **variable decelerations** on fetal heart monitoring, not a persistent high-resistance Doppler pattern in the umbilical artery.
Question 3: A 42-year-old woman with previously regular 28-day cycles now reports cycles varying from 24-35 days over the past year. Day 3 labs show: FSH 18 mIU/mL (normal: 3-10), LH 10 mIU/mL, estradiol 35 pg/mL, AMH 0.4 ng/mL (normal age 40-44: 0.5-2.5). She has three children and desires no future pregnancies but wants to understand her physiology. Evaluate these findings and synthesize the underlying pathophysiologic process.
A. Normal perimenopausal transition with declining ovarian reserve and altered follicular dynamics (Correct Answer)
B. Autoimmune oophoritis causing accelerated follicular atresia
C. Polycystic ovary syndrome with age-related metabolic changes
D. Primary ovarian insufficiency requiring hormone replacement therapy
E. Hypothalamic dysfunction from chronic stress affecting GnRH pulsatility
Explanation: ***Normal perimenopausal transition with declining ovarian reserve and altered follicular dynamics***
- The elevated **FSH** and low **AMH** (0.4 ng/mL) indicate a declining number of viable follicles and reduced **Inhibin B** production, leading to loss of negative feedback on the pituitary.
- Variable cycle lengths are a hallmark of the **perimenopause**, caused by inconsistent follicular recruitment and fluctuations in **estrogen** levels as the ovarian supply depletes.
*Autoimmune oophoritis causing accelerated follicular atresia*
- **Autoimmune oophoritis** is a rare cause of primary ovarian insufficiency, often associated with other endocrinopathies like **Addison's disease**.
- It typically presents with a more aggressive depletion of the follicular pool and is not the most likely diagnosis in a 42-year-old with expected age-related changes.
*Polycystic ovary syndrome with age-related metabolic changes*
- **PCOS** is characterized by **hyperandrogenism** and polycystic morphology, typically presenting with elevated **AMH** levels rather than the low levels seen here.
- While PCOS causes irregular cycles, it usually manifests as **oligomenorrhea** (long cycles) rather than the short cycles seen in early menopausal transition.
*Primary ovarian insufficiency requiring hormone replacement therapy*
- **Primary ovarian insufficiency (POI)** is defined by the loss of ovarian function before age **40**, whereas this patient is 42.
- POI typically requires **FSH levels >40 mIU/mL** on two occasions to meet diagnostic criteria, while her level of 18 is consistent with the **transition phase**.
*Hypothalamic dysfunction from chronic stress affecting GnRH pulsatility*
- Functional hypothalamic amenorrhea is characterized by **low or inappropriately normal FSH** and LH due to suppressed **GnRH pulsatility**.
- This patient's high **FSH** and low **AMH** clearly point to an ovarian source of dysfunction rather than a **hypothalamic-pituitary** failure.
Question 4: A 38-year-old G3P2 woman at 39 weeks gestation presents in active labor. She has a history of postpartum hemorrhage with her second delivery requiring transfusion. After delivery of the infant, the placenta is delivered intact 8 minutes later. Her obstetrician administers oxytocin. Ten minutes postpartum, she has moderate vaginal bleeding. Analyze the physiologic mechanisms and determine the most likely cause of bleeding.
A. Retained placental fragments preventing uterine contraction
B. Placenta accreta with incomplete separation
C. Vaginal or cervical laceration from delivery
D. Uterine atony despite oxytocin administration (Correct Answer)
E. Coagulopathy from amniotic fluid embolism
Explanation: ***Uterine atony despite oxytocin administration***
- **Uterine atony** is the leading cause of **postpartum hemorrhage (PPH)**, responsible for approximately 80% of cases, and occurs when the myometrium fails to contract effectively.
- Physiologically, myometrial contraction acts as "**living ligatures**" to compress **spiral arteries**; failure of this mechanism causes significant bleeding even if the placenta is delivered intact.
*Retained placental fragments preventing uterine contraction*
- This cause is unlikely here as the clinical description stating the **placenta is delivered intact** at 8 minutes postpartum contradicts this diagnosis.
- Retained products of conception typically prevent the uterus from fully involuting, but the **intact delivery** points toward a different primary mechanism.
*Placenta accreta with incomplete separation*
- **Placenta accreta** involves an abnormal attachment to the myometrium and usually presents with a **delayed third stage of labor** or a fragmented placenta.
- Since the placenta separated naturally and was delivered only **8 minutes** after the infant, a morbidly adherent placenta is ruled out.
*Vaginal or cervical laceration from delivery*
- Trauma-related bleeding usually presents as a **steady stream of bright red blood** despite a **firm, well-contracted uterine fundus**.
- While possible, the patient's **prior history of PPH** and the high prevalence of atony make a failure of the physiological contraction mechanism more probable.
*Coagulopathy from amniotic fluid embolism*
- **Amniotic fluid embolism (AFE)** is a rare, catastrophic event often accompanied by sudden **hypotension**, **seizures**, or **cardiorespiratory collapse**.
- Isolated moderate vaginal bleeding without systemic signs of **disseminated intravascular coagulation (DIC)** or respiratory distress makes AFE a highly unlikely cause.
Question 5: A 26-year-old woman with regular menses undergoes hormonal evaluation on day 3 of her cycle: FSH 8 mIU/mL, LH 6 mIU/mL, estradiol 45 pg/mL. On day 14, repeat testing shows: FSH 10 mIU/mL, LH 42 mIU/mL, estradiol 250 pg/mL. On day 21: progesterone 16 ng/mL, estradiol 150 pg/mL. Analyze this hormonal pattern to identify the physiologic mechanism driving the day 14 LH surge.
A. Positive feedback from sustained high estradiol levels on the hypothalamic-pituitary axis (Correct Answer)
B. Decreased negative feedback from declining FSH concentrations
C. Direct stimulation of pituitary by inhibin B from dominant follicle
D. Decreased progesterone-mediated negative feedback allowing LH release
E. GnRH-independent pulsatile LH secretion from pituitary gonadotrophs
Explanation: ***Positive feedback from sustained high estradiol levels on the hypothalamic-pituitary axis***
- The mid-cycle **LH surge** is triggered when **estradiol** levels remain elevated above a critical threshold (typically >200 pg/mL) for at least 48 hours.
- This high estradiol concentration switches from its usual negative feedback effect to **positive feedback**, increasing **GnRH pulse frequency** and pituitary sensitivity to GnRH.
*Decreased negative feedback from declining FSH concentrations*
- While **FSH** does decline slightly due to **inhibin B** and estrogen feedback during the follicular phase, this decline does not trigger the LH surge.
- The LH surge is an active, positive stimulus rather than a passive response to the removal of **FSH-mediated inhibition**.
*Direct stimulation of pituitary by inhibin B from dominant follicle*
- **Inhibin B** is primarily responsible for the **negative feedback** that suppresses FSH levels to ensure the selection of a single dominant follicle.
- **Inhibin B** does not stimulate LH secretion; the LH surge is specifically driven by **estrogen** signaling.
*Decreased progesterone-mediated negative feedback allowing LH release*
- **Progesterone** is at very low levels (basal) during the follicular phase and only rises significantly (as seen on day 21) after **ovulation** has occurred.
- The LH surge happens before the **luteal phase** rise in progesterone, meaning the removal of progesterone inhibition cannot be the driving mechanism.
*GnRH-independent pulsatile LH secretion from pituitary gonadotrophs*
- LH secretion is highly dependent on **pulsatile GnRH** release from the hypothalamus; without GnRH, the mid-cycle surge would not occur.
- The surge represents a massive increase in **pituitary responsiveness** and GnRH output, rather than an autonomous pituitary event.
Question 6: A 29-year-old woman at 10 weeks gestation develops severe hyperemesis gravidarum. Ultrasound reveals a complete hydatidiform mole. Her serum hCG is 500,000 mIU/mL. She undergoes suction curettage. Two weeks post-procedure, her hCG is 50,000 mIU/mL. Four weeks post-procedure, it is 45,000 mIU/mL. Analyze these findings to determine the most appropriate next step.
A. Continue weekly hCG monitoring as normal decline is occurring
B. Begin multi-agent chemotherapy with EMA-CO regimen
C. Initiate single-agent methotrexate chemotherapy for gestational trophoblastic neoplasia (Correct Answer)
D. Repeat suction curettage for retained molar tissue
E. Perform hysterectomy for definitive treatment
Explanation: ***Initiate single-agent methotrexate chemotherapy for gestational trophoblastic neoplasia***
- The patient's **hCG level has plateaued** (less than 10% change) over two weeks, which meets the criteria for diagnosing **Gestational Trophoblastic Neoplasia (GTN)** following a molar evacuation.
- **Single-agent chemotherapy** with **methotrexate** or actinomycin D is the standard first-line treatment for low-risk GTN (FIGO score <7), offering a high cure rate while preserving fertility.
*Continue weekly hCG monitoring as normal decline is occurring*
- A normal response requires a continuous decline; a **plateau or rise** in hCG levels is a definitive indication that the disease has progressed to GTN.
- Delaying treatment when a plateau is identified increases the risk of **local invasion** or **metastatic spread** of the trophoblastic tissue.
*Begin multi-agent chemotherapy with EMA-CO regimen*
- **EMA-CO** (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) is reserved for **high-risk GTN** (FIGO score ≥7).
- This patient is classified as low-risk due to her young age, lack of metastases, and short interval since the **index pregnancy**.
*Repeat suction curettage for retained molar tissue*
- Repeat **suction curettage** is generally not recommended as it increases the risk of **uterine perforation**, hemorrhage, and infection without addressing systemic disease.
- It is ineffective for treating **invasive moles** or **choriocarcinoma** that have penetrated the myometrium or spread vascularly.
*Perform hysterectomy for definitive treatment*
- **Hysterectomy** is an aggressive surgical intervention usually reserved for patients who have completed childbearing or have **chemoresistant** disease.
- For a 29-year-old seeking to maintain **reproductive potential**, medical management with chemotherapy is the preferred and highly effective approach.
Question 7: A 35-year-old woman undergoes in vitro fertilization with embryo transfer on day 3 post-retrieval. Her ovarian stimulation protocol included recombinant FSH and GnRH antagonist, with hCG trigger 36 hours before retrieval. On the day of transfer (day 3), what would be the expected dominant hormone maintaining the endometrium, and what is its primary source?
A. Estradiol from the developing embryo
B. Progesterone from adrenal glands under ACTH stimulation
C. hCG from early embryonic trophoblast cells
D. Progesterone from corpora lutea formed after oocyte retrieval (Correct Answer)
E. Estradiol from residual follicular cells
Explanation: ***Progesterone from corpora lutea formed after oocyte retrieval***
- Following the **hCG trigger** and extraction of oocytes, the remaining granulosa and theca cells within the aspirated follicles undergo **luteinization** to form multiple **corpora lutea**.
- These corpora lutea secrete high levels of **progesterone**, which is the dominant hormone required for converting the endometrium from a proliferative to a **secretory state** to allow for embryo implantation.
*Estradiol from the developing embryo*
- A day 3 embryo (cleavage stage) is metabolically active but does not produce **estradiol** in quantities sufficient to maintain the endometrium.
- The embryo's primary role in early signaling is the production of **hCG**, but this typically begins significantly later at the **blastocyst** stage after implantation.
*Progesterone from adrenal glands under ACTH stimulation*
- While the **adrenal glands** produce small amounts of progesterone precursors, they are not the primary source for maintaining the **endometrium** during the luteal phase or pregnancy.
- Endometrial maintenance is strictly dependent on **ovarian steroidal output** (corpus luteum) or exogenous supplementation in an ART cycle.
*hCG from early embryonic trophoblast cells*
- On day 3 post-retrieval, the embryo is at the **cleavage stage** (typically 6-8 cells) and has not yet differentiated into **trophoblast cells**.
- Significant **hCG production** only occurs after the blastocyst implants into the uterine wall, which happens roughly 6-10 days after fertilization.
*Estradiol from residual follicular cells*
- Although residual follicular cells (luteinized granulosa cells) do secrete **estradiol**, it is not the dominant hormone responsible for **endometrial maintenance** in the post-ovulatory phase.
- **Progesterone** is the specific and critical hormone required to stabilize the endometrial lining and support a potential pregnancy during the **luteal phase**.
Question 8: A 24-year-old nulliparous woman presents with secondary amenorrhea for 6 months. She is a competitive marathon runner training 70 miles per week with 12% body fat. Labs show: LH 1.2 mIU/mL (normal follicular phase: 2-10), FSH 2.1 mIU/mL (normal: 3-10), estradiol 15 pg/mL (normal follicular: 30-100), prolactin 14 ng/mL (normal: <25), TSH 2.1 mIU/L. Apply these findings to determine the mechanism of her amenorrhea.
A. Primary ovarian insufficiency from autoimmune destruction
B. Asherman syndrome from endometrial adhesions
C. Pituitary adenoma causing hyperprolactinemia
D. Hypothalamic amenorrhea from energy deficit and low leptin (Correct Answer)
E. Polycystic ovary syndrome with LH/FSH ratio abnormality
Explanation: ***Hypothalamic amenorrhea from energy deficit and low leptin***
- Intense exercise and low body fat cause **functional hypothalamic amenorrhea (FHA)** by disrupting the pulsatile release of **GnRH**, resulting in a **hypogonadotropic hypogonadal** state.
- Low **leptin** levels, a consequence of decreased adipose tissue, signal the hypothalamus to suppress the reproductive axis to conserve energy during a major energy deficit.
*Primary ovarian insufficiency from autoimmune destruction*
- This condition presents with **hypergonadotropic hypogonadism**, characterized by **elevated FSH/LH** levels rather than the low levels seen here.
- It involves premature depletion of ovarian follicles and would not be directly caused by high-intensity athletic training.
*Asherman syndrome from endometrial adhesions*
- This is a structural cause of amenorrhea typically following **uterine instrumentation** or infection, with normal endocrine profiles.
- This patient’s **low estradiol** and gonadotropins point to a central hormonal issue rather than a uterine outflow tract abnormality.
*Pituitary adenoma causing hyperprolactinemia*
- A prolactinoma would result in an **elevated prolactin level**, which suppresses GnRH and causes amenorrhea.
- In this case, the **prolactin level is normal** (14 ng/mL), ruling out hyperprolactinemia as the etiology.
*Polycystic ovary syndrome with LH/FSH ratio abnormality*
- PCOS usually presents with an **increased LH/FSH ratio** and signs of hyperandrogenism rather than low gonadotropin levels.
- Patients with PCOS typically have **normal or elevated estrogen** levels, unlike the low estrogen (15 pg/mL) consistent with hypothalamic suppression.
Question 9: A 32-year-old woman at 8 weeks gestation presents with nausea and vomiting. Laboratory studies show: hCG 150,000 mIU/mL (expected for gestational age: 50,000-100,000 mIU/mL), TSH 0.1 mIU/L (normal: 0.4-4.0), free T4 1.8 ng/dL (normal: 0.8-1.8). She has no personal or family history of thyroid disease. Apply your understanding of pregnancy hormones to explain these findings.
A. Pre-existing Graves disease unmasked by pregnancy
B. Thyroid adenoma with autonomous function
C. Hyperemesis gravidarum with secondary hyperthyroidism
D. hCG-mediated thyroid stimulation causing gestational thyrotoxicosis (Correct Answer)
E. Twin pregnancy with pathologic thyroid hormone elevation
Explanation: ***hCG-mediated thyroid stimulation causing gestational thyrotoxicosis***
- Human chorionic gonadotropin (**hCG**) shares a common **alpha-subunit** with **TSH**, allowing it to directly stimulate the **TSH receptors** on the thyroid gland when present in high concentrations.
- This pathology, known as **gestational transient thyrotoxicosis**, results in high **free T4** levels and a feedback-suppressed **TSH**, typically peaking when hCG levels are highest around 8-12 weeks gestation.
*Pre-existing Graves disease unmasked by pregnancy*
- **Graves disease** would typically present with **exophthalmos**, pretibial myxedema, or a diffuse goiter, which are not mentioned in this patient.
- While pregnancy can alter the clinical course of autoimmune states, the lack of a personal/family history and the timing suggest a **hCG-driven** etiology rather than **TSH receptor antibodies**.
*Thyroid adenoma with autonomous function*
- An **autonomous thyroid adenoma** would present as a **solitary nodule** on physical examination and is not classically triggered by the onset of pregnancy.
- Diagnosis would require **iodine scintigraphy** or ultrasound showing a specific focal lesion, whereas this case is driven by systemic **hCG elevation**.
*Hyperemesis gravidarum with secondary hyperthyroidism*
- While this patient has nausea and vomiting, **hyperemesis gravidarum** is a clinical diagnosis characterized by severe, persistent vomiting leading to **dehydration** and weight loss.
- The laboratory findings described are the *cause* (due to **hCG**) rather than a secondary result of the vomiting itself, making the physiologic mechanism of **hCG-mediated stimulation** the more accurate explanation.
*Twin pregnancy with pathologic thyroid hormone elevation*
- While a **twin pregnancy** significantly increases **hCG** levels and can lead to thyrotoxicosis, the hormone elevation itself is a physiologic response to the high hCG rather than a "pathologic" source from the thyroid gland.
- There is no clinical data provided, such as an **ultrasound**, to confirm multiple gestations in this specific 8-week presentation.
Question 10: A 28-year-old woman presents to the clinic for evaluation of infertility. Her menstrual cycles have been regular every 28 days. She reports using basal body temperature charting, which shows a biphasic pattern with temperature elevation occurring around day 14. Serum progesterone is measured on day 21 of her cycle and is found to be 18 ng/mL (normal luteal phase >10 ng/mL). Based on this information, what is the most likely status of her ovulatory function?
A. Anovulatory cycles with inadequate corpus luteum function
B. Polycystic ovary syndrome with irregular ovulation
C. Premature ovarian insufficiency
D. Normal ovulation with adequate luteal phase (Correct Answer)
E. Luteinized unruptured follicle syndrome
Explanation: ***Normal ovulation with adequate luteal phase***
- The patient exhibits regular 28-day cycles and a **biphasic basal body temperature**, which are hallmark clinical indicators of successful **ovulation**.
- A **serum progesterone level of 18 ng/mL** on day 21 (mid-luteal phase) is well above the threshold of 10 ng/mL, confirming a functional **corpus luteum**.
*Anovulatory cycles with inadequate corpus luteum function*
- Anovulatory cycles typically result in **monophasic** temperature charts and low progesterone levels (<3 ng/mL) throughout the cycle.
- **Luteal phase deficiency** would present with progesterone levels below 10 ng/mL or a shortened luteal phase duration, which is not the case here.
*Polycystic ovary syndrome with irregular ovulation*
- **PCOS** is characterized by **oligomenorrhea** or amenorrhea, whereas this patient has perfectly regular menstruation every 28 days.
- Clinical or biochemical **hyperandrogenism** is usually present in PCOS, and temperature charts are typically erratic or monophasic.
*Premature ovarian insufficiency*
- Patients with **POI** experience irregular periods or **amenorrhea** before age 40, often accompanied by symptoms of estrogen deficiency like hot flashes.
- Diagnostic markers for POI include an **elevated FSH** level (>25-40 mIU/mL), which would preclude the regular cyclic progesterone production seen here.
*Luteinized unruptured follicle syndrome*
- While **LUFS** can produce progesterone and a biphasic temperature chart, it is characterized by the failure of the **oocyte** to release despite luteinization.
- Given the clinical evidence of normal luteal function and regular cycles, **normal ovulation** is the most likely status until further imaging (like USG) proves otherwise.
